Nuwellis, Inc.
NUWE- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001506492
No open-market purchases or sales by Nuwellis, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $63.9K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Nuwellis, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 10 | 12 | +2 |
| Shares | 37.5K | 213.1K | +175.6K (+468.2%) |
| Value | $53.6K | $123.1K | +$69.5K (+129.7%) |
New holders (4)
Institutions that held Nuwellis, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 54,800 | $32.0K | 0.00% |
| Virtu Financial LLC | 54,507 | $31.0K | 0.00% |
| Goldman Sachs Group Inc | 21,692 | $12.6K | 0.00% |
| Citadel Advisors LLC | 19,489 | $11.2K | 0.00% |
Sold out (2)
Institutions that held Nuwellis, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| UBS Group AG | 117 | $167 |
| Royal Bank of Canada | 16 | $0 |